FDA approves Novartis' copycat of blockbuster Biogen drug
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2023 Earnings Call. [Operator Instructions].
LLY earnings call for the period ending June 30, 2023.
ELAN earnings call for the period ending June 30, 2023.